[HTML] springer.com

[HTML][HTML] Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease

WC Lee, TW Liao, TY Chen, HY Fang, YN Fang… - … Drugs and Therapy, 2024 - Springer
Background Impaired renal function is frequently observed in patients with heart failure and
reduced ejection fraction (HFrEF). The differential effect of sacubitril/valsartan and …
被引用次数：4 相关文章

Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease.

WC Lee, TW Liao, TY Chen, HY Fang… - … Drugs and Therapy, 2023 - europepmc.org
Background Impaired renal function is frequently observed in patients with heart failure and
reduced ejection fraction (HFrEF). The differential effect of sacubitril/valsartan and …

Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease.

WC Lee, TW Liao, TY Chen, HY Fang… - … Drugs & Therapy, 2024 - search.ebscohost.com
Background: Impaired renal function is frequently observed in patients with heart failure and
reduced ejection fraction (HFrEF). The differential effect of sacubitril/valsartan and …
[HTML] nih.gov

[HTML][HTML] Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease

WC Lee, TW Liao, TY Chen, HY Fang… - … Drugs and Therapy, 2024 - ncbi.nlm.nih.gov
Background Impaired renal function is frequently observed in patients with heart failure and
reduced ejection fraction (HFrEF). The differential effect of sacubitril/valsartan and …

Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease

WC Lee, TW Liao, TY Chen, HY Fang… - … Drugs and Therapy, 2023 - pure.lib.cgu.edu.tw
Background: Impaired renal function is frequently observed in patients with heart failure and
reduced ejection fraction (HFrEF). The differential effect of sacubitril/valsartan and …

Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease

WC Lee, TW Liao, TY Chen… - … drugs and therapy, 2024 - pubmed.ncbi.nlm.nih.gov
Background Impaired renal function is frequently observed in patients with heart failure and
reduced ejection fraction (HFrEF). The differential effect of sacubitril/valsartan and …
[PDF] academia.edu

[PDF][PDF] Sacubitril/valsartan improves all‑cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease

WC Lee, TW Liao, TY Chen, HY Fang, YN Fang… - parameters, 2023 - academia.edu
Background Impaired renal function is frequently observed in patients with heart failure and
reduced ejection fraction (HFrEF). The differential effect of sacubitril/valsartan and …

Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease.

WC Lee, TW Liao, TY Chen, HY Fang… - … Drugs and Therapy, 2023 - europepmc.org
Background Impaired renal function is frequently observed in patients with heart failure and
reduced ejection fraction (HFrEF). The differential effect of sacubitril/valsartan and …

Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease

WC Lee, TW Liao, TY Chen, HY Fang… - … Drugs and Therapy, 2023 - pure.lib.cgu.edu.tw
Background: Impaired renal function is frequently observed in patients with heart failure and
reduced ejection fraction (HFrEF). The differential effect of sacubitril/valsartan and …